EUCTR2008-004669-24-GB进行中(未招募)不适用
itrous Oxide and Cerebral Autoregulation
Research Innovation Services, University of Nottingham0 个研究点目标入组 20 人开始时间: 2008年10月3日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •age between 18 and 50 years
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •those with history or evidence of systemic illness or vascular disease
- •those taking prescription medication which may affect the cardiovascular system
- •any evidence of neurological disorder
- •pregnant or lactating females
研究者
相似试验
进行中(未招募)
1 期
itrous oxide and cerebral vasodilatation: a dose-response study in healthy volunteersThe study will be conducted in healthy volunteers. I will evaluate the effects of inhaled concentrations of nitrous oxide, ranging from 0% to 50%, on cerebral blood flow and cerebral vascular tone in a dose related manner.EUCTR2007-007094-23-GBniversity of Nottingham20
Unknown
不适用
Continous Assessment of Cerebral Autoregulation With Near-infrared SpectroscopyCerebral Blood FlowCerebral Perfusion PressureNCT02959008Yu Liyun40
已完成
不适用
The Analysis of Autonomic Nervous System, Oxidative Stress, Metabolites according to Exercise Intensity of Aerobic Exercise in Sleep Deficiency ConditioKCT0006684Korea University32
已完成
不适用
Cerebral rSO2(regional saturation of oxygen) monitoring in cardiopulmonary arrest patients :non randomized prospective multicenter studycardiopulmonary arrest patients on arrival at hospitalJPRN-UMIN000025684Department of raumatology and Acute Critical Medicine Osaka University Graduate School of Medicine225
尚未招募
不适用
Brain blood flow responses in preterm babies treated with indomethacin or ibuprofen for patent ductus arteriosuspatent ductus arteriosusACTRN12618001049268A/Prof Michael Stark50
